Overseas venture capital enterprises account for 96.6%
According to the analysis of the report recently, thanks to the government policies and the efforts of the private sector, the number of venture capital enterprises in China is increasing, but compared with the global market, the domestic demand oriented venture capital enterprises are carrying out structured operation. It is worth noting that export risk enterprises with core competitive advantages based on technology have good growth potential in the global market, so they should be actively supported. According to the association of venture enterprises, compared with price (11.0%) and production (17.2%), export venture enterprises take technology and knowledge (55.0%) as their core power to answer the questions. According to statistics, the innovative constitution based on technology is also very good. In particular, the report points out that the grass-roots development of risk enterprises with the power of globalization is limited. According to the results of the analysis, the global market competitiveness and global innovation competitiveness of export risk enterprises account for 3 out of 5 points respectively. However, the global market competitiveness and global innovation competitiveness are only 3 points.
Only 32.5% of the global forces have an advantage. This means that there are fewer global activities that contribute positively to the competitiveness of venture enterprises. Therefore, although venture capital enterprises are committed to making up for the open innovation of their own insufficient assets through cooperation with external entities, there are some problems in the process of promotion, such as the lack of systematic promotion ability, in the case of global open innovation with cooperative objects as overseas entities. The results of global open innovation are also at a low level. According to the report, the impact of global technical cooperation results due to product development or the contribution of new partners is also very low. In other words, the government should strive to create an environment that makes it easier for venture enterprises to promote the global open innovation strategy. In addition, according to the sales volume of 34 hospitals in 2018, 13 large enterprises achieved 1.072 billion won, small and medium enterprises reached 1.432 billion won (21), and venture enterprises reached 451 billion won (7). Compared with last year, they increased by 7.5%, 14.9% and 13.5% respectively. In terms of operating profit margin, large enterprises, small and medium-sized enterprises and risk enterprises increased by 11.9%, 4.8% and 9.4% respectively.
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
in-cosmetics Global launches the first Nutricosmetics Ingredient Index
-
in-cosmetics Global reveals line-up for 2026 programme curated for innovation
-
IN-COSMETICS GLOBAL TO LAUNCH FIRST DEDICATED INNER BEAUTY ZONE FOR NUTRICOSMETIC INNOVATIONS IN 2026
-
COSMOPROF WORLDWIDE BOLOGNA 2026: A GLOBAL BEAUTY ECOSYSTEM IN CONTINUOUS EVOLUTION
-
French Cosmetics Exports Poised for First Drop in Over Two Decades in 2025
-
Cocamidopropyl Betaine: Uses, Benefits, and Safety
-
Pierre Fabre established a new cosmetics innovation center in Shanghai, China
-
COSME Tokyo International Cosmetics Trade Fair 2024
-
Beauty Expo Australia 2023
-
COSMOPROF WORLDWIDE BOLOGNA 2024
Recommend Reading
-
Eurofragance Launches Proprietary Fragrance Ingredient Olivante
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
Natura &Co Returns to Profitability in Q2 with Strong Latin America Performance
-
Safic-Alcan Acquires Anders, Expanding Latin American Presence
-
Procter & Gamble Exits Pakistan Amid Economic Pressures, Ending Three Decades of Operations
-
Supply Recovery Limited & Cost Decline: PP Market Shakes and Faces Potential Drop
-
Lithium Carbonate May Remain in a Volatile Range in June
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Supply Tightens, Demand Holds Strong—Hydrogen Peroxide Prices Soar
-
Insufficient Support, May Butanol Prices in China Decrease by Nearly 10%